GlassScriptPhysician profile
K George Thampy
NPI 1205816790
$35,227.07
in general payments reported to CMS, 2019-2025
50 companies · $2,815 in 2025
The $2,815 reported for 2025 was more than what 82% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,354 · 2020: $2,512 · 2021: $9,144 · 2022: $4,653 · 2023: $4,968 · 2024: $2,781 · 2025: $2,815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,399 · Consulting Fee: $1,153 · Travel and Lodging: $12.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,398.53 |
| Consulting Fee | $1,153.00 |
| Travel and Lodging | $12.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,130.81 | 2019-2025 | Freestyle Libre 3 |
| Medtronic Minimed, INC. | $6,674.05 | 2019-2020 | |
| Medtronic, INC. | $5,301.19 | 2021-2025 | Minimed 780g |
| Novo Nordisk INC | $3,517.25 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $2,474.53 | 2019-2025 | Evenity, Prolia, Repatha |
| Abbvie INC. | $1,704.91 | 2019-2025 | Creon, Synthroid |
| Dexcom, INC. | $1,410.18 | 2019-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $760.65 | 2021-2025 | |
| Amarin Pharma, INC. | $754.87 | 2019-2022 | |
| Nevro Corp. | $703.89 | 2022-2024 | Senza |
| Ibsa Pharma INC. | $426.76 | 2020-2025 | Tirosint, Tirosint, Licart |
| Horizon Therapeutics Plc | $407.97 | 2019-2023 | Tepezza |
| Sanofi-Aventis U.S. LLC | $399.01 | 2024-2025 | |
| Madrigal Pharmaceuticals | $237.58 | 2024-2025 | Rezdiffra, Resmetirom |
| Corcept Therapeutics | $237.15 | 2020-2025 | Korlym |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $200.62 | 2025 | Senza |
| Sequel Med Tech, LLC | $196.80 | 2025 | Twiist |
| Nestle Healthcare Nutrition INC. | $193.79 | 2020-2023 | |
| Xeris Pharmaceuticals, INC. | $192.24 | 2020-2023 | Gvoke Hypopen, Keveyis |
| Renalytix Ai, INC. | $188.02 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Mannkind Corporation | $187.46 | 2019-2023 | Afrezza |
| Recordati_rare_diseases_inc. | $186.81 | 2021-2023 | Isturisa, Signifor Lar |
| Neurocrine Biosciences, INC. | $165.93 | 2025 | |
| Smith+Nephew, INC. | $157.43 | 2023 | Collagenase Santyl, Regranex |
| Opko Pharmaceuticals, LLC | $137.86 | 2019 | |
| Ascendis Pharma Endocrinology INC | $135.52 | 2023 | |
| Alfasigma USA, INC. | $131.50 | 2020-2022 | |
| Aimmune Therapeutics, INC. | $129.08 | 2024-2025 | Zenpep |
| Becton, Dickinson and Company | $105.17 | 2019-2022 | |
| Lifescan, INC. | $78.14 | 2020-2023 | |
| Intuity Medical INC | $72.71 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Companion Medical, INC. | $70.57 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $66.55 | 2019 | |
| Eusa Pharma (US) LLC | $52.29 | 2022 | |
| Embecta Corp. | $52.02 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Chiesi USA, INC. | $49.54 | 2024 | Myalept, Mycapssa |
| Eisai INC. | $43.51 | 2019-2020 | |
| Esperion Therapeutics, INC. | $38.27 | 2020 | |
| Shire North American Group INC | $32.93 | 2019 | |
| Echosens North America, INC. | $28.00 | 2023 | Fibroscan |
| Averitas Pharma INC. | $27.90 | 2025 | Qutenza |
| Cequr Corporation | $23.61 | 2023 | Cequr Simplicity |
| Rhythm Pharmaceuticals, INC. | $21.47 | 2025 | Imcivree |
| Ultragenyx Pharmaceutical INC. | $21.11 | 2021 | |
| Radius Health, INC. | $18.76 | 2020 | |
| Merck Sharp & Dohme LLC | $18.03 | 2020 | |
| Alexion Pharmaceuticals, INC. | $17.25 | 2023 | Strensiq |
| Novartis Pharmaceuticals Corporation | $16.68 | 2023 | |
| Senseonics, Incorporated | $15.00 | 2019 | |
| Kyowa Kirin, INC. | $13.70 | 2024 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw K Thampy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.